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Abstract：Our previous studies have shown that subjective symptoms and ventilatory
function are improved by spa therapy in patients with chronic obstructive pulmonary
disease (COPD). In the present study, we investigated the effects of spa therapy on
six-minute walk distance in patients with COPD. Subjects were 10 patients with
chronic obstructive pulmonary disease (9 males and 1 female) admitted to our hospital
to undergo pulmonary rehabilitation. All patients had complex spa therapy (swimming
training in a hot spring pool, inhalation of iodine salt solution, and fango therapy) for
4 weeks. Ventilatory function, six-minute walk distance, oxygen saturation and Borg
scale were measured. Vital capacity, forced expiratory volume in one second, six-
minute walk distance and oxygen saturation increased, but not significantly. Signifi-
cant decreases were observed for Borg scale. We found that spa therapy improved
ventilatory dysfunction and six-minute walk distance in patients with COPD. The re-
sults demonstrated that spa therapy may lead to better disease control and exercise
tolerance in patients with COPD.
Key words：Chronic obstructive pulmonary disease, Spa therapy, Six-minute walk test,
Borg scale, Ventilatory function
Introduction
The usual course of chronic obstructive pul-
monary disease (COPD) is a slow worsening of
ventilatory function accompanied by gradually
increasing symptoms of cough , phlegm and
breathlessness and impairment of functional ca-
pacity culminating in chronic respiratory failure.
The response to treatment is often disappointing
with only supplemental oxygen having been
shown to alter the natural history. However,
pharmacotherapy has an important role in the
management of COPD as it is possible to pro-
vide symptomatic relief and often some improve-
ment in ventilatory function and exercise capacity.
Inhaled corticosteroid, anticholinergic agent,
long-acting β２-agonist, and theophylline are the
mainstay of treatment as per the current guide-
line for the management of COPD１). However,
for some patients with COPD,tiotropium bromide,
fluticasone, procaterol and theophylline may fail
to achieve adequate control.
Our previous studies have shown that subjec-
tive symptoms and ventilatory function are im-
proved by spa therapy in patients with pulmo-
nary emphysema２-５).
The assessment of disability in patients with
COPD usually requires that the practitioners
estimate the patient's capacity for exercise.
Methods of assessing the performance of whole
body exercise include tests of maximal capacity
and endurance capacity. The six-minute walk
test is now the most commonly used timed
walked test６-７). It is simple, and does not re-
quire sophisticated equipment or advanced tech-
nical training. In addition, walking is a familiar
activity typically performed by even the most se-
verely debilitated patients６,８). In the six-minute
walk test, the patient determines the walking
speed, and the distance walked will depend on
the patient's capacity to pace himself or herself
accordingly. But the effects of spa therapy on
six-minute walk test have not been clear.
In the present study, we investigated the ef-
fects of spa therapy on walking distance during
the six-minute walk test in patients with COPD.
Materials and methods
Subjects were 10 patients with COPD (9
males and 1 female) admitted to our hospital to
undergo pulmonary rehabilitation. All patients
were ex-smokers. The mean age of the patients
was 74.9 years (range, 63 to 81). The mean
duration of COPD was 6.6 years. The diagnosis
of COPD was performed by clinical symptoms,
auscultation findings of the lung, ventilatory
function, chest X-ray findings and ％LAA<-950
HU of the lung on HRCT, as previously de-
scribed９). All patients showed a difference be-
tween prebronchodilator and postbronchodilator
values of forced expiratory volume in one sec-
ond (FEV1.0) not exceeding 15％. All patients
had complex spa therapy (swimming training in a
hot spring pool, inhalation of iodine salt solution,
and fango therapy) for 4 weeks10,11). The charac-
teristics of the subjects in this study are shown
in Table１.
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Table 1  Backgrounds of patients 
Patients (male/female) 10 (9/1) 
Age (years) 74.96.0 (63-81) 
Onset (years) 68.314.4 (30-79) 
Severity of chronic obstructive 
pulmonary disease  
Stage 
Stage 
Stage 
Stage 
      
        1 
              5 
              4 
0
Ventilatory function tests, vital capacity (VC),
forced vital capacity (FVC) , FEV1.0 , forced
expiratory flow after 25％ of expired FVC (FEF25),
forced expiratory flow after 50％ of expired FVC
(FEF50), forced expiratory flow after 75％ of ex-
pired FVC (FEF75), mean expiratory flow dur-
ing the middle half of the FVC (FEF25-75), peak
expiratory flow (PEF), residual volume (RV),
functional residual capacity (FRC) and diffusing
capacity for carbon monoxide (DLco), were
performed in all subjects using a CHESTAC 33
(Chest Co) linked to a computer. DLco was
measured by the single breath technique using
a CHESTAC 33. The values of RV, FRC, PEF
and DLco for each patient were expressed as a
percent of the predicted values12) . Broncho-
dilators were withheld prior to measurements of
lung function for more than 12 hours.
The six-minute walk test was carried out in a
hospital corridor, which is 100 m. Subjects
were instructed to walk as fast as possible for 6
minutes and to cover as much ground as possi-
ble in that time. They were allowed to slow
down or stop if necessary, but were required to
resume walking as soon as they felt able. Each
minute subjects were given feedback on the
elapsed time, and were encouraged to continue
walking. All subjects were familiar with the six-
minute walk test prior to the study.
Data shown in this paper are presented as
mean±SEM. Statistically significant differences
of the mean were estimated using the unpaired
Student's t-test. A p value of <0.05 was re-
garded as significant. Analyses were performed
using StatView 5.0 (Abacus Concepts, Inc.,
Berkeley, CA).
Results
VC, FVC, FEV1.0, FEV75, FEV50, FEV25,
FEV25-75, ％FRC, ％PEF, ％DLco values slightly
increased, the increase in the 10 parameters
was not significant. ％RV value slightly decrea-
sed, the decrease was not significant (Table２).
Six-minute walk distance values before and af-
ter spa therapy were 288±104 m and 327±109
m, respectively (p>0.05). Significant decrease
was observed in maximum Borg Scale values
following spa therapy for 4 weeks (2.0±1.3
and 1.6±1.3) (p<0.05). Minimum oxygen
saturation values and oxygen saturation values
at rest slightly increased, but not significantly.
Heart rate at rest and maximum heart rate
slightly decreased, but not significantly (Table３).
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Table 2  Changes of ventilatory parameters by spa therapy  
 Spa therapy 
 Before 4weeks 
VC() 2.420.64 2.790.70 
FVC() 2.150.84 2.650.74 
FEV1() 1.170.57 1.440.70 
FEF75(/sec) 1.771.37 2.291.86 
FEF50(/sec) 0.700.58 0.780.61 
FEF25(/sec) 0.220.08 0.250.12 
FEF25-75(/sec) 0.750.57 0.910.73 
%RV(%) 152.237.5 149.435.4 
%FRC(%) 102.428.1 109.318.9 
%PEF(%) 40.715.8 50.628.0 
%DLco(%) 51.525.7 57.131.1 
                                 
VC:vital capacity, FVC:forced vital capacity 
FEV1: forced expiratory volume in one second 
FEF75: forced expiratory flow after 75% of expired FVC 
FEF50: forced expiratory flow after 50% of expired FVC 
FEF25: forced expiratory flow after 25% of expired FVC 
FEF25-75: mean expiratory flow during the middle half of FVC 
RV: residual volume, FRC: functional residual capacity 
PEF: peak expiratory flow, DLco: diffusing capacity for carbon monoxide 
Table 3  Changes of six-minute walk test by spa therapy 
 Spa therapy  
 Before 4weeks 
Walk distasnce () 288104 327109 
Maximum Borg scale   2.01.3   1.61.3 a
Minimum SpO2 (%) 87.15.9 88.58.0 
SpO2 at rest (%) 95.81.9 96.61.0 
Heart rate at rest (/min) 72.78.5 72.84.3 
Maximum Heart rate 
(/min) 
103.917.7 115.617.4 
                                  
a:p<0.05 
SpO2: oxygen saturation 
COPD is considered one of the major public
health problems in the world13). It was recently
defined as a disease characterized by airflow
limitation, not fully reversible14,15), usually prog-
ressive, and accompanied by an abnormal pul-
monary inflammatory response to noxious gases
or particles16).
Our previous studies have shown that spa
therapy improves ventilatory parameters in pa-
tients with COPD２-４). However, it is still un-
clear whether spa therapy improves six-minute
walk distance.
The six-minute walk test is simple to perform,
has been standardized17) and predicts the risk of
death in COPD patients18,19). Its use as a clinical
tool has gained acceptance, since it is a good
predictor of the risk of death among patients
with other chronic diseases, including conges-
tive heart failure20) and pulmonary hypertension21),
and COPD18). Indeed, the distance walked in
six minutes has been accepted as a good out-
come measure after interventions such as pul-
monary rehabilitation22).
In this study, effects of spa therapy on pul-
monary emphysema were examined in relation
to six-minute walk distance and we found that
six-minute walk distance was improved by spa
therapy.
Mucociliary clearance is an effective and es-
sential biological barrier against microorganisms
and particulate matter. This specialized apparatus
consists of secretory cells and ciliated cells that
beat in a coordinated and metachronal fashion.
Their propulsive force mobilizes the mucus blan-
ket toward the larynx for elimination. Dysfunc-
tion of the mucociliary clearance is a common
respiratory disturbance in patients with obstruc-
tive lung disease such as chronic bronchitis,
asthma, bronchiectasis, and cystic fibrosis.
This dysfunction is an important marker of ac-
celerated loss of ventilatory function in COPD23).
Our previous studies have demonstrated that
spa therapy improved mucociliary clearance and
ventilatory dysfunction24-27). Suzuki reported that
there was significant correlation between six-
minute walk distance values and ventilatory
function28).
In the present study, we examined the effects
of spa therapy in six-minute walk test in patients
with COPD and we found that spa therapy im-
proved ventilatory dysfunction and six-minute
walk distance in patients with COPD.
In conclusion, to our knowledge, this is the
first study to look at the effects of spa therapy
on the six-minute walk test in patients with
COPD. The results demonstrated that spa ther-
apy may influence on six-minute walk test and
lead to better disease control and exercise toler-
ance in patients with COPD.
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慢性閉塞性肺疾患患者における温泉療法の６分間
歩行に対する効果
高田真吾１), 芦田耕三１), 保泰弘１),
濱田全紀２), 岩垣尚史１), 菊池 宏１),
光延文裕１)
岡山大学病院三朝医療センター内科１)
同 三朝医療センターリハビリテーション科２)
我々は温泉療法が慢性閉塞性肺疾患患者に対し
て, 呼吸機能改善効果を有することを報告してき
た｡ 今回我々は慢性閉塞性肺疾患患者を対象に温
泉療法の６分間歩行試験に及ぼす影響について検
討した｡ 当院入院中の慢性閉塞性肺疾患患者10例
(男性９例, 女性１例) を対象として, 温泉プー
ル水中運動, 鉱泥湿布療法, ヨードゾル吸入療法
等による複合温泉療法を4週間施行し, その間の
呼吸機能, ６分間歩行試験における歩行距離, 動
脈血酸素飽和度, 修正Borgスケールの変化を比
較検討した｡ 呼吸機能検査では, 肺活量, １秒量
等の改善傾向が認められた｡ ６分間歩行距離, 動
脈血酸素飽和度は上昇傾向にあった｡ 修正Borg
スケールは有意に低下傾向した｡ 温泉療法により
呼吸機能の改善が得られ, これにより動脈血酸素
飽和度及び６分間歩行距離が上昇したと考えられ
た｡ 温泉療法が慢性閉塞性肺疾患の治療に有用で
あることが示唆された｡
検索用語：慢性閉塞性肺疾患, 温泉療法, ６分間
歩行試験, ボルグスケール, 呼吸機能
